Volume 12, Issue 2 (4-2022)                   JABS 2022, 12(2): 140-151 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahidi S, Tahmasebi Fard Z. Impacts of BMI & IL-4 Genetic Polymorphisms (rs2243250 C/T & rs2227284 A/C) on Iranian Breast Cancer Patients: a Pilot Study. JABS 2022; 12 (2) :140-151
URL: http://jabs.fums.ac.ir/article-1-2767-en.html
1- Department of Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
2- Department of Biology, Roudehen Branch, Islamic Azad University, Roudehen, Iran , ztahmasebifard@yahoo.com
Abstract:   (2204 Views)
Background & Objective: Breast cancer is a phenotypically complex and diverse genetic disease caused by changes in the structure and expression of specific genes. Immune system factors are also involved in the etiology of this neoplasm. This study aimed to evaluate the effect of genetic changes (rs2243250 & rs2227284) on the interleukin 4 gene and body mass index on breast cancer risk in Iranian women.
Material & Methods: From women referring to Shohada-Tajrish Hospital, 100 women with breast cancer and 100 healthy women were selected. After blood sampling and DNA extraction, the women’s genotypes were determined using the RFLP-PCR technique. The results were evaluated by SPSS software version 21 and chi-square and logistic regression tests.
Results: Analysis of the results with different genetic models showed the effect of rs2243250 on breast cancer (p<0.05), but rs2227284 was not associated with breast cancer (p>0.05). People with the CC / TT genotype (polymorphism) were more likely to get breast cancer. Also, the increase in body mass index was significantly associated with both polymorphisms studied. Also, carriers of the TT genotype of rs2243250 polymorphism were more likely to develop breast cancer with aging.
Conclusion: Genetic alterations in the IL-4 gene and obesity probably contribute to breast cancer, and carriers of both genetic modifications (CC / TT) are more likely to develop breast cancer.

 
Full-Text [PDF 263 kb]   (621 Downloads)    
Type of Study: Research | Subject: Cellular-Molecular Biology
Received: 2021/12/11 | Accepted: 2022/02/1 | Published: 2022/06/28

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)